Skin biopsy test detects abnormalities of key biomarker in neurodegenerative disorders by Jen Brogan | Mar 25, 2024 | News | 0 Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders Read More
Key Parkinson’s protein could offer new potential targets for treatment by Jen Brogan | Dec 20, 2023 | News | 0 The findings could lead to new treatments to target the mTOR and ease PD symptoms Read More